<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01415648</url>
  </required_header>
  <id_info>
    <org_study_id>STIC/10/02</org_study_id>
    <secondary_id>2010-A01167-32</secondary_id>
    <nct_id>NCT01415648</nct_id>
  </id_info>
  <brief_title>Medico-economic Evaluation of Preoperative Cerebral Oximetry Monitoring During Carotid Endarterectomy</brief_title>
  <acronym>EMOCAR</acronym>
  <official_title>Medico-economic Evaluation of Preoperative Cerebral Oximetry Monitoring During Carotid Endarterectomy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nantes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nantes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In France, in 2007, 17 000 patients underwent carotid endarterectomy. The risk of having an
      ipsilateral postoperative stroke after carotid endarterectomy remains at 1-1.5%. There is no
      consensus concerning the best cerebral monitoring and hemodynamic optimisation during carotid
      cross-clamping.

      The objective of this prospective, multicentric, double-blinded and randomized study is to
      evaluate the interest of continuous cerebral oximetry monitoring by INVOS™ cerebral oximeter
      to direct the hemodynamic optimisation during carotid endarterectomy and reduce the new-onset
      of postoperative radiological (MRI) ischemic lesions. A cost/effectiveness analysis will be
      conducted to estimate the impact of this monitoring versus standard care on direct and
      indirect postoperative costs during 120 days.

      A substudy will evaluate the effect of this monitoring on neurocognitive outcome and on a
      serum marker of brain injury, protein S-100B
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After consent, patients will be randomized in two groups: one group with continuous per
      operative cerebral oximetry monitoring associated with hemodynamic optimisation algorithm
      (excluding norepinephrine) if cerebral oximetry decrease more than 15% under the preoperative
      baseline; the second group is continuously monitored with cerebral oximeter but this latter
      is blinded to the medical team, the alarm switch off , and patients are managed with the
      standard care of the centre.

      All patients have a preoperative and a postoperative diffusion cerebral MRI to detect new
      onset of cerebral ischemic lesion. The amount and the volume of cerebral ischemic lesions
      will be scored to compare groups.

      Quality of life as well as direct (medical and nonmedical) and indirect costs were collected
      using questionnaires during the 120 postoperative days.

      A substudy including 200 patients will be conducted to compare the two groups concerning
      postoperative protein S-100B level and a composite score of neurocognitive tests (measured
      pre- and postoperatively) The trial will be conducted according to GCP
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Recruitment time expired.
  </why_stopped>
  <start_date>April 2011</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of new cerebral ischemic lesions</measure>
    <time_frame>Up to one month post-operative</time_frame>
    <description>The number of new cerebral ischemic lesions observed on postoperative diffusion MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incremental cost-effectiveness ratio comparing the group monitored by cerebral oximeter and the standard care group</measure>
    <time_frame>4 months post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospitalization length of stay and direct medical costs</measure>
    <time_frame>4 months post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurologic and neurocognitive postoperative disorders</measure>
    <time_frame>1 month post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative quality of life (SF36, EQ5D tests)</measure>
    <time_frame>4 months post-operative</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral desaturation threshold assessment</measure>
    <time_frame>4 months post-operative</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">879</enrollment>
  <condition>Internal Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>open NIRS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous per operative cerebral oximetry monitoring (using INVOS™ cerebral oximeter) associated with hemodynamic optimisation algorithm (excluding norepinephrine) if cerebral oximetry decrease more than 15% under the preoperative baseline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Blinded NIRS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Continuously monitored with cerebral oximeter but this latter is blinded to the medical team, the alarm switch off , and patients are managed with the standard care of the centre</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cerebral oximetry monitoring using INVOS™ and hemodynamic optimisation</intervention_name>
    <description>continuous per operative cerebral oximetry monitoring associated with hemodynamic optimisation algorithm (excluding norepinephrine) if cerebral oximetry decrease more than 15% under the preoperative baseline</description>
    <arm_group_label>open NIRS</arm_group_label>
    <other_name>INVOS™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard cerebral monitoring and hemodynamic optimisation</intervention_name>
    <description>the patient is continously monitored with cerebral oximeter but this latter is blinded to the medical team, the alarm switch off , and patients are managed with the standard care of the centre.</description>
    <arm_group_label>Blinded NIRS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients (male-female) over 18 y.o.

          -  Presenting an internal carotid stenosis requiring surgery

          -  Mini Mental State Examination &gt;24 during preoperative examination

          -  Informed written consentExclusion Criteria:

        Exclusion criteria:

          -  Severe renal failure or requiring dialysis

          -  Liver failure or cirrhosis (Child class ≥ B) or prothrombin activity&lt;50%

          -  Heart failure (NYHA ≥ III), left ventricular ejection fraction &lt; 40%, acute coronary
             syndrome,

          -  Associated surgery

          -  Pregnancy

          -  Contraindication to MRI

          -  History of allergy to modified gelatine or starch

          -  History of allergy to adhesive part of electrode
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yann Le Teurnier, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Nantes</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Besancon University Hospital &quot;Hôpital Jean Minjoz&quot;</name>
      <address>
        <city>Besancon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bordeaux University Hospital &quot;Haut Lévêque&quot;</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bordeaux University Hospital &quot;Hôpital Pellegrin&quot;</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brest University Hospital &quot;La Cavale Blanche&quot;</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Caen University Hospital &quot;Côte de Nacre&quot;</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dijon University Hospital &quot;Le Bocage&quot;</name>
      <address>
        <city>Dijon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Le Mans Hospital</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital de Marie Lannelongue Plessis Robinson</name>
      <address>
        <city>Le Plessis Robinson</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lyon University Hospital &quot;Hôpital Edouard Herriot&quot;</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marseille University Hospital &quot;Hôpital de la Timone&quot;</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Nouvelles Cliniques Nantaises&quot;</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nice University Hospital &quot;Saint-Roch&quot;</name>
      <address>
        <city>Nice</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Groupe Hospitalier Saint-Joseph&quot;</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;Hôpital Européen Georges Pompidou&quot;</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Reims University Hospital &quot;Robert Debré&quot;</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital &quot;Pontchaillou&quot;</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Strasbourg University Hospital</name>
      <address>
        <city>Strasbourg</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toulouse University Hospital</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 11, 2011</study_first_submitted>
  <study_first_submitted_qc>August 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2011</study_first_posted>
  <last_update_submitted>August 26, 2016</last_update_submitted>
  <last_update_submitted_qc>August 26, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>with surgical indication</keyword>
  <keyword>Cerebral oximetry</keyword>
  <keyword>carotid endarterectomy</keyword>
  <keyword>MRI</keyword>
  <keyword>ischemic lesion</keyword>
  <keyword>cost/effectiveness analysis</keyword>
  <keyword>Neurocognitive Outcome</keyword>
  <keyword>protein S-100B</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

